medigraphic.com

2013, Number S5

Revista Habanera de Ciencias Médicas 2013; 12 (S5)

Temporal arteritis. A literature review

Castañeda BRÁ, Guerra CO

Language: Spanish
References: 34
Page: 24-32
PDF size: 50.68 Kb.


ABSTRACT

Introduction: the temporal arteritis is a giant cell arteritis, the most common in the population with more than fifty years, and usually are misdiagnosed.
Objectiv: to show novel elements in the diagnosis: clinical feature, histochemical aspects, and imagenology of this arteritis.
Material and Methods: reference systems such as MEDLINE, PUBMED, SCIELO and ESBCO were consulted. It was also made a revision of descriptors like temporal arteritis, giant cell arteritis, clinical feature, and images findings.
Results: is a most common giant cell arteritis in patients with more than fifty years old, associated usually to immunosenescence, genetics factors and viral infections; the biopsy is a main resource in its diagnosis. Steroids, immunosupresors and monoclonal antibodies have been used in its treatment.
Conclusions: the temporal arteritis is a immunomediated giant cell arteritis, aging associated, with varied clinical feature and specifics laboratory parameters, treated with different therapies but the steroids therapy is predominant.


REFERENCES

  1. Mathew T, Aroor S. Temporal arteritis: A case series from south India and an update of the Indian scenario. Ann Indian Acad Neurol. [Serial on the Internet]. 2012, Jan; 15(1): 27-30. [Cited February 15, 2013]. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299067/

  2. Mohan S, Liao Y. Giant cell arteritis: immune and vascular aging as disease risk factors. Arthritis Res Ther. [Serial on the Internet]. 2011; 13(4): 231. [Cited February 16, 2013]. Disponible en: http://www.biomedcentral.com/content/pdf/ar3358.pdf

  3. Kesten F, Aschwanden M. Giant cell arteriitis a changing entity. Swiss Med Wkly. [serial on the Internet]. 2011;141(3):272. [Cited February 17, 2013]. Disponible en: http://www.isdbweb.org/documents/file/4eaab3b48c10a.pdf

  4. Horton BT, Brown GE. An undescribed form of arteritis of the temporal vessels. Proc Staff Meet Mayo Clin. 1932;7:700.

  5. Davies C, May DJ. The role of temporal artery biopsies in giant cell arteritis. Ann R Coll Surg Engl. [Serial on the Internet]. 2011;93(1): 4-5. [Cited February 16, 2013]. Available from: MEDLINE with Full Text. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293260/

  6. Kawasaki A, Purvin V. Giant Cell arteritis: an updated review. Acta Ophthalmol. [serial on the Internet]. 2009; 87(1): 13-22. [Cited February 17, 2013]. Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/j.1755-3768.2008.01314.x/full

  7. Rössler T, Tuchen S, Hofmüller W, Wecke T, Vorwerk C, Behrens-Baumann W, et al. [Giant cell arteritis (temporal arteritis, Horton's arteritis): clinical characteristics and management]. Klinische Monatsblätter Für Augenheilkunde. [Serial on the Internet]. 2012, Mar; 229(3): 246-254. [Cited February 14, 2013]. Disponible en: http://cat.inist.fr/?aModele=afficheN&cpsidt=25478597

  8. Chaigne-Delalande S, de Menthon M, Lázaro E, Mahr A. [Giant-cell arteritis and Takayasu arteritis: epidemiological, diagnostic and treatment aspects]. Presse Médicale. [Serial on the Internet]. 2012, Oct; 41(10): 955-965. [Cited February 14, 2013]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22940467

  9. Rheumatology Expert Group. Polymyalgia rheumatics and giant cell arteritis. Therapeutic Guidelines:Reumatology Melbourne Therapeutic Guidelines,2010 (Citado Abril13 del 2012). Disponible en: http://cat.inist.fr/?aModele=afficheN&cpsidt=25478597

  10. Weyand C, Younge B. IFN-ã and IL-17, The Two Faces of T Cell Pathology in Giant Cell Arteritis. Curr Opin Rheumatol. [Serial on the Internet]. 2012;23(1):43-49. [Cited February 16, 2013]. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081721/

  11. González-Gay MA, Vázquez-Rodríguez TR, López-Díaz MJ, Miranda-Filloy JA, González-Juanatey C, Martín J, et al. Epidemiology of giant cell arteriitis and polymyalgia rheumatica. Arthritis Rheum. [Serial on the Internet]. 2009; 61(10):145461.[CitedFebruary15,2013]. Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/art.24459/full

  12. Juanatey C, Martín J, Llorca J. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. [revista en la Internet]. 2009, Ago; 61:14541461. [Citado 2013 Feb 14].Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/art.24459/full

  13. Mohammadini A, Pfeiffer J. Association between human papillomavirus DNA and temporal arteritis. BMC Musculoskelet Disord. [Serial on the Internet]. 2012; 13(2): 132. [Cited February 15, 2013]. Disponible en: http://www.biomedcentral.com/1471-2474/13/132/

  14. Santos-Bueso E, Sáenz-Francés F, García-Sánchez J. Arteritis de la temporal de Francesco Giamberti. Patología Ocular en la obra de Piero de Cosimo. Arch.Soc Esp.Oftalmol. [Serial on the Internet]. 2011;86(11):385-386. [Cited February 15, 2013]. Available from: MEDLINE with Full Text: http://scielo.isciii.es/pdf/aseo/v86n11/iconografica.pdf

  15. Asensio-Sánchez VM, Morales-Gómez I, Rodríguez-Vaca I. Parálisis del tercer par craneal como única manifestación de arteritis de la temporal oculta. Arch Soc Esp Oftalmol [revista en la Internet]. 2009 Ago; 84(8): 395-398. [Citado 2013 Feb 16]. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0365 -66912009000800005&lng=es. http://dx.doi.org/10.4321/S0365-66912009000800005 .

  16. Uffelmann N, Kozzel J . Reticulated lesion as an early diagnostic sign for giant cell arteritis. Dermatology Online Journal. [revista en la Internet]. 2012, Ago; 18(6): 6. [Citado 2013 Feb 16]. Disponible en: http://escholarship.org/uc/item/7bn752md

  17. JCS Joint Working Group. Guideline for management of vasculitis syndrome. Circulation Journal. [Serial on the Internet]. 2011;75(2):474503. [Cited February 16, 2013]. Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/art.24459/full

  18. Olivera S, Amores B, Torralba MA, Pérez Calvo JI. Paciente con complicación poco frecuente de arteritis de células gigantes. Anales Sis San Navarra [revista en la Internet]. 2010 Dic; 33(3): 327-330. [Citado 2013 Feb 16]. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1137-66272010000400011&lng=es. http://dx.doi.org/10.4321/S1137-66272010000400011 .

  19. Alexandra Villa-Forte. Giant cell arteritis: Suspect it, treat it promptly Clinic Journal of Medicine. [revista en la Internet]. 2011; 78:265-70. [Citado 2013 Feb 15]. Disponible en: http://171.66.127.177/content/78/4/265.

  20. Dasgupta B, Borg FA, Hassan N, et al. BSR and BHPR Standards, Guidelines and Audit Working Group BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology (Oxford). [Serial on the Internet]. 2010; 49:15941597. [Cited February 15, 2013].Disponible en: http://rheumatology.oxfordjournals.org/content/49/8/1594.

  21. Aikaterini A, Miltiades K, Meletios K, and Sfikakis P.The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis BMC Musculoskelet Disord. [revista en la Internet]. 2010; 11(1):44.[Citado 2013 Feb 16]. Disponible en: http://www.biomedcentral.com/1471-2474/11/44

  22. Papathanasiou ND, Du Y, Menezes LJ, Al-Muhaideb A, Shastry M, Beynon H, et al. 18F-Fluorodeoxyglucose PET/CT in the evaluation of large-vessel vasculitis: diagnostic performance and correlation with clinical and laboratory parameters. Br J Radiol. [revista en la Internet]. 2010; 54(1):3. [Citado 2013 Feb 16]. Disponible en: http://link.springer.com/article/10.1007/s10067-011-1828-9

  23. Morinobu A, Tsuji G, Kasagi S, Saegusa J, Hayashi H, Kumagai S, et al. Role of imaging studies in the diagnosis and evaluation of giant cell arteritis in Japanese: report of eight cases. Modern Rheumatology / The Japan Rheumatism Association.[Serial on the Internet]. 2011, Aug; 21(4): 391-396. [Cited February 14, 2013]. Disponible en: http://link.springer.com/article/10.1007/s10165-010-0408-1

  24. Blockmans D, Bley T, Schmidt W. Imaging for large-vessel vasculitis. Curr Opin Rheumatol.[revista en la Internet]. 2009;21(1):19-28. [Citado 2013 Feb 15]. Disponible en: http://www.biomedcentral.com/1471-2474/11/44

  25. Bogaard K, Schrama JG,Voogel AJ, Zwijnenburg A, Ezechiels JP. Detection of Giant Cell Aortitis Using 18F-Fluorodeoxyglucose Positron Emission Tomography Computed Tomography. Circulation Journal. [revista en la Internet]. 2010; 122: 411-412. [Citado 2013 Feb 16]. Disponible en: http://circ.ahajournals.org/content/122/5/e411

  26. Saedon H, Saedon M. Temporal artery biopsy for giant cell arteritis: retrospective audit. JRSM Short Rep. [Serial on the Internet]. 2012, Oct; 3(10): 73 [Cited February 15, 2013]. Disponible en: http://shr.sagepub.com/content/3/10/73

  27. Mandell BF, Hoffman GS. Enfermedades reumáticas y sistema cardiovascular en Tratado de Cardiología de Braunwald, Madrid, España: Eds. Elsevier ; 2006, p. 2103-2105.

  28. Durant C, Connault J, Graveleau J, Toquet C, Brisseau J, Hamidou M. Juvenile temporal vasculitis: a rare case in a middle-aged woman. Annals Of Vascular Surgery. [Serial on the Internet]. 2011, Apr; 25(3): 384. [Cited February 14, 2013].Disponible en: http://www.sciencedirect.com/science/article/pii/S0890509610004681

  29. Charlton R. Optimal management of giant cell arteritis and polymyalgia rheumatica. Ther Clin Risk Manag. [Serial on the Internet]. 2012, Apr; 8(2): 173-179. [Cited February 16, 2013]. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333461/

  30. Balsalobre Aznar J, Porta-Etessam J. [Temporal arteritis: treatment controversies]. Neurología (Barcelona, Spain). [Serial on the Internet]. 2010, Sep; 25(7): 453-458. [Cited February 14, 2013]. Disponible en: http://www.sciencedirect.com/science/article/pii/S0213485310001246

  31. Lurati A, Bertani L. Successful Treatment of a Patient with Giant Cell Vasculitis (Horton Arteritis) with Tocilizumab a Humanized Anti-Interleukin-6 Receptor Antibody. Case Report Rheumatol). [Serial on the Internet]. 2012, Apr. [Cited February 14, 2013]. Disponible en: http://www.hindawi.com/crim/rheumatology/2012/639612/

  32. Schmidt J, Warrington KJ. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management. Drugs Aging. [Serial on the Internet].2011; 28:65166.[Cited February 16, 2013].Disponible en: http://link.springer.com/article/10.2165/11592500-000000000-00000

  33. Fraser J, Weyand C. The Treatment of Giant Cell Arteritis. Rev Neurol Dis. [revista en la Internet]. 2008, Ago; 5(3): 140152. [Citado 2013 Feb 14]. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014829/

  34. Hassan N, Dasgupta B, Barraclough K. Giant cell arteritis. BMJ. [Serial on the Internet]. 2011;342:d3019. [Cited 2013 Feb 16]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21606138




2020     |     www.medigraphic.com